target prediction for an open access set of compounds
play

Target Prediction for an Open Access Set of Compounds Active - PowerPoint PPT Presentation

Jan 22, 2024 •115 likes •431 views

Target Prediction for an Open Access Set of Compounds Active against Mycobacterium tuberculosis Francisco Martnez-Jimnez XII Jornadas de Bioinformtica , Sevilla Thursday, September 25, 14 One third of the worlds population is infected

  1. Target Prediction for an Open Access Set of Compounds Active against Mycobacterium tuberculosis Francisco Martínez-Jiménez XII Jornadas de Bioinformática , Sevilla Thursday, September 25, 14

  2. One third of the world’s population is infected with Mycobacterium tuberculosis, the causative agent of tuberculosis. WHOTuber2012. Global Tuberculosis Report 2012. Thursday, September 25, 14

  3. Tuberculosis incidence... Estimated new TB cases (all forms) per 100 000 population 0–24 25–49 50–149 150–299 ≥ 300 No estimate Not applicable Thursday, September 25, 14

  4. MultiDrugResistant-TB Percentage notified of estimated MDR-TB cases 0–9.9 10–19.9 20–49.9 50–79.9 ≥ 80 ≤ 1 MDR-TB case estimated No data Not applicable Thursday, September 25, 14

  5. Phenotypic screening against Mycobacterium tuberculosis Ballell, L.et al (2013). Fueling open-source drug discovery: 177 small-molecule leads against tuberculosis. ChemMedChem . Thursday, September 25, 14

  6. 776 compounds chemical features Thursday, September 25, 14

  7. Phenotypic screenings � � �� �������������������� �� ���������������������� �� ��������� �� �� �� �������������� �������������� �� �� �� �� �� �� �� � �� � � ���� ���� ���� ���� ���� ���� ���� ���� ���� ���� ���� ���� ���� ���� ���� ���� ���� ���� ���� ���� ���� ���� Figure 3 | Cumulative distribution of new drugs by discovery Swinney, D.C. & Anthony, J. How were new medicines discovered? Nat. Rev. Drug Discov ��������������� � ��������������� Thursday, September 25, 14

  8. Finding out the mode of action... Phenotype Thursday, September 25, 14

  9. Finding out the mode of action... Phenotype Thursday, September 25, 14

  10. Methods 2D-Chemogenomics Historical Approach 3D-Structural Approach Approach George Papadatos Vinod Kumar Francisco Martínez-Jiménez John P . Overington James Brown Marc A. Martí-Renom Thursday, September 25, 14

  11. Similar binding-sites tend to bind similar ligands Activin receptor type-1 co-crystallized A3F Similar binding-sites AQ4 co-crystallized Epidermal growth factor receptor Thursday, September 25, 14

  12. Similar binding-sites tend to bind similar ligands Activin receptor type-1 co-crystallized A3F Similar binding-sites AQ4 co-crystallized Epidermal growth factor receptor Thursday, September 25, 14

  13. Similar binding-sites tend to bind similar ligands Activin receptor type-1 Similar ligands co-crystallized VGM A3F Similar binding-sites AQ4 co-crystallized Epidermal growth factor receptor Thursday, September 25, 14

  14. Similar binding-sites tend to bind similar ligands Activin receptor type-1 Similar ligands co-crystallized VGM A3F Similar binding-sites AQ4 co-crystallized Epidermal growth factor receptor Thursday, September 25, 14

  15. Network-based Method nAnnolyze Thursday, September 25, 14

  16. Applying the method, modeling genomes... 2. Binding-site inheritance 1. Modeling 3D model Mycobacterium smegmatis Mycobacterium tuberculosis Mycobacterium bovis Ursula Pieper PDB templates Andrej Sali Bacterial proteomes 3D reliable models 5,008 no overlapping Different Proteins 5,008 different proteins Inherited binding-sites 30,000 Thursday, September 25, 14

  17. Looking for targets... t1 t2 GSK . Drug . . tN Thursday, September 25, 14

  18. Looking for targets... t1 t2 GSK . Drug . . tN Thursday, September 25, 14

  19. Looking for targets... t1 t2 GSK . Drug . . tN Thursday, September 25, 14

  20. Looking for targets... t1 t2 GSK . Drug . . tN Ligand Target Distance Global Z-score Local Z-score GSK1 pknB Kinase 1.3 -1.6 -2.5 GSK1 mapB 2.5 2.3 1.02 GSK1 sahH 1.9 -1.6 -3.16 GSK1 Mmpl3 2.6 2.42 2.97 Thursday, September 25, 14

  21. Statistical assessment of predicted links between compounds and targets • We merged all the predictions from the 3 methods. • Significance of links using groups of similar compounds and the targets KEGG pathways . • LogOdds. Odds of an observation given its probability. • p-value using Fisher´s exact test for 2x2 contingency table comparing two groups of annotations. Thursday, September 25, 14

  22. Compound dataset diversity Thursday, September 25, 14

  23. Compound dataset diversity Thursday, September 25, 14

  24. Targeting essential aminoacids metabolism pathways LogOdds Probability .0 .01 .02 .03 .04 .05 .06 .07 -1.5 0 1.5 mtu00400 mtu00410 mtu03410 mtu00550 mtu03420 mtu00290 mtu00300 mtu00250 HIST CHEM mtu00623 1 mtu00860 2 10 mtu00450 mtu00660 11 mtu00562 2 24 mtu00740 mtu01053 34 mtu00780 mtu00521 Streptomycin biosynthesis Folate biosynthesis mtu00790 STR Nitrogen metabolism mtu00910 mtu00970 Aminoacyl-tRNA biosynthesis Purine metabolism mtu00230 mtu00311 Penicillin and cephalosporin biosynthesis D-Arginine and D-ornithine metabolis mtu00472 One carbon pool by folate mtu00670 Thursday, September 25, 14

  25. Significant drug-protein pairs MoA Prediction against TB Table 2. Significant links between GSK compound families and KEGG pathways. Table 2. Cont. GSK Family Compound Target Pathways GSK Family Compound Target Pathways 1 GSK975784A Glycerolipid metabolism (mtu00561) GSK1829729A Rv3855 No Pathway Rv2182c Rv0053 Ribosome (mtu03010) Glycerophospholipid metabolism (mtu00564) Rv0379 No Pathway Rv2483c No Pathway Rv0650 Glycolysis/Gluconeogenesis (mtu00010) GSK975810A Glycerolipid metabolism (mtu00561) Rv2182c Galactose metabolism (mtu00052) Glycerophospholipid metabolism (mtu00564) Starch and sucrose metabolism (mtu00500) Rv2483c No Pathway Amino sugar & nucl. sugar metab. (mtu00520) Streptomycin biosynthesis (mtu00521) GSK975839A Rv2182c Glycerolipid metabolism (mtu00561) Glycerophospholipid metabolism (mtu00564) GSK1829816A Rv0053 Ribosome (mtu03010) Rv2483c No Pathway Rv0379 No Pathway Rv2299c No Pathway Rv0650 Glycolysis/Gluconeogenesis (mtu00010) Galactose metabolism (mtu00052) GSK975840A Glycerolipid metabolism (mtu00561) Rv2182c Starch and sucrose metabolism (mtu00500) Glycerophospholipid metabolism (mtu00564) Amino sugar & nucl. sugar metab. (mtu00520) Rv2483c No Pathway Streptomycin biosynthesis (mtu00521) GSK975842A Glycerolipid metabolism (mtu00561) Rv2182c GSK479031A Rv0053 Ribosome (mtu03010) Glycerophospholipid metabolism (mtu00564) Rv0379 NoPathway (mtu00000) Rv2483c No Pathway Rv0650 Glycolysis/Gluconeogenesis (mtu00010) Rv2045c No Pathway Galactose metabolism (mtu00052) Rv2139 Pyrimidine metabolism (mtu00240) Starch and sucrose metabolism (mtu00500) Rv2299c No Pathway Amino sugar & nucl. sugar metab. (mtu00520) Rv2483c No Pathway Streptomycin biosynthesis (mtu00521) 3 GSK957094A Rv3170 Gly, Ser and Thr metabolism (mtu00260) GSK547481A Rv0194 ABC transporters (mtu02010) Arginine and proline metabolism (mtu00330) GSK547490A Rv0194 ABC transporters (mtu02010) Histidine metabolism (mtu00340) Tyrosine metabolism (mtu00350) GSK547491A Rv0194 ABC transporters (mtu02010) Phenylalanine metabolism (mtu00360) GSK547499A Rv0194 ABC transporters (mtu02010) Tryptophan metabolism (mtu00380) Rv0053 Ribosome (mtu03010) GSK547500A Rv0194 ABC transporters (mtu02010) Rv0379 No Pathway GSK547511A Rv0194 ABC transporters (mtu02010) Rv0650 Glycolysis/Gluconeogenesis (mtu00010) Galactose metabolism (mtu00052) GSK547512A Rv0194 ABC transporters (mtu02010) Starch and sucrose metabolism (mtu00500) GSK547527A Rv1640c Aminoacyl-tRNA biosynthesis (mtu00970) Amino sugar & nucl. sugar metab. (mtu00520) Rv3598c Aminoacyl-tRNA biosynthesis (mtu00970) Streptomycin biosynthesis (mtu00521) Rv0194 ABC transporters (mtu02010) 9 GSK1188379A Rv0194 ABC transporters (mtu02010) GSK547528A Rv1640c Aminoacyl-tRNA biosynthesis (mtu00970) GSK1188380A Rv0194 ABC transporters (mtu02010) Rv3598c Aminoacyl-tRNA biosynthesis (mtu00970) 16 GSK1825940A Rv0194 ABC transporters (mtu02010) Rv0194 ABC transporters (mtu02010) GSK1825944A Rv0194 ABC transporters (mtu02010) GSK547543A Rv0194 ABC transporters (mtu02010) 35 BRL-10143SA Rv1649 Aminoacyl-tRNA biosynthesis (mtu00970) 7 GSK1829727A Rv0053 Ribosome (mtu03010) Rv2763c One carbon pool by folate (mtu00670) Rv0379 No Pathway Folate biosynthesis (mtu00790) Rv0650 Glycolysis/Gluconeogenesis (mtu00010) One carbon pool by folate (mtu00670) Galactose metabolism (mtu00052) Rv2764c Pyrimidine metabolism (mtu00240) Starch and sucrose metabolism (mtu00500) Amino sugar & nucl. sugar metab. (mtu00520) BRL-51093AM Rv2763c One carbon pool by folate (mtu00670) Rv2764c Folate biosynthesis (mtu00790) Streptomycin biosynthesis (mtu00521) One carbon pool by folate (mtu00670) Thursday, September 25, 14

Recommend

Open Access and Beyond: Policy and Best Practices NFAIS Open Access and Beyond Conference

Open Access and Beyond: Policy and Best Practices NFAIS Open Access and Beyond Conference

Open Access and Beyond: Policy and Best Practices NFAIS Open Access and Beyond Conference October 2-3, 2017 | Alexandria, VA Jerry Sheehan Deputy Director National Library of Medicine, NIH, HHS Public Access Well-Established PMC articles

286 views • 25 slides
Prediction of RNA-RNA-Interaction 20 1 15 1 5 10 20 5 10 20 15 10 1 15 5 1 20 10

Prediction of RNA-RNA-Interaction 20 1 15 1 5 10 20 5 10 20 15 10 1 15 5 1 20 10

Prediction of RNA-RNA-Interaction 20 1 15 1 5 10 20 5 10 20 15 10 1 15 5 1 20 10 Can Alkan, Emre Karakoc, Joseph H. Nadeau, S. Cenk Sahinalp, Kaizhong Zhang. RNA-RNA interaction prediction and antisense RNA target search. JCB

627 views • 14 slides
DBAASP Special prediction as a tool for the prediction of antimicrobial potency against particular

DBAASP Special prediction as a tool for the prediction of antimicrobial potency against particular

DBAASP Special prediction as a tool for the prediction of antimicrobial potency against particular target species Boris Vishnepolsky 1, *, Maya Grigolava 1 , George Zaalishvili 2 , Margarita Karapetian 2 and Malak Pirtskhalava 1, * 1 I.Beritashvili

987 views • 23 slides
CONCERT/Springer Open Access Seminar Open Access From Green Road To Gold Road April 26, 2013

CONCERT/Springer Open Access Seminar Open Access From Green Road To Gold Road April 26, 2013

CONCERT/Springer Open Access Seminar Open Access From Green Road To Gold Road April 26, 2013 What Im Going To Talk About The University of Calgary brief introduction Open Access Authors Fund The Open Access suite at the

499 views • 22 slides
A prediction is not a decision -- it is only a component of a decision. Prediction

A prediction is not a decision -- it is only a component of a decision. Prediction

A prediction is not a decision -- it is only a component of a decision. Prediction Machines , Agarwal, et.al. ? Prediction + Judgement = Decision "Open the pod bay doors, Hal" 2001: A Space Odyssey How far should we go?

327 views • 6 slides
Target setting for universal access Group 4 Rapporteur: Rachel Ong Target setting for

Target setting for universal access Group 4 Rapporteur: Rachel Ong Target setting for

Target setting for universal access Group 4 Rapporteur: Rachel Ong Target setting for Universal Access External issues Internal issues Insufficient funding for scaling Many obstacles to scaling up up being faced, e.g. human

46 views • 3 slides
Open Access for All Thats not too much to ask, is it? Update on Some Access Issues 1.

Open Access for All Thats not too much to ask, is it? Update on Some Access Issues 1.

Fair, Shared and Sustainable Open Access for All Thats not too much to ask, is it? Update on Some Access Issues 1. River Wye Glasbury-Hay a) Fishery owner threatening legal action against canoe hire company o Could become a

141 views • 11 slides
What I will talk about today A Newer Perspective Similarities between OA and open data

What I will talk about today A Newer Perspective Similarities between OA and open data

Be More Open: A Newcomers Perspective on Lessons Learned (or not) About Opening Access Within Scholarly Communication Meredith Morovati @datadryad 8 th conference on open access scholarly publishing @OASPA PROMOTING SCHOLARSHIP THROUGH OPEN

528 views • 25 slides
ALADIN: A New Approach for Drug Target Interaction Prediction Krisztian Buza a , Ladislav

ALADIN: A New Approach for Drug Target Interaction Prediction Krisztian Buza a , Ladislav

ALADIN: A New Approach for Drug Target Interaction Prediction Krisztian Buza a , Ladislav Peka b a Knowledge Discovery and Machine Learning Rheinische Friedrich-Wilhelms-Universitt Bonn, Germany b Faculty of Mathematics and Physics

370 views • 14 slides
The EC/OpenAIRE FP7 Post-Grant Open Access Pilot What is this FP7 Post-Grant Pilot? The EC

The EC/OpenAIRE FP7 Post-Grant Open Access Pilot What is this FP7 Post-Grant Pilot? The EC

Pablo de Castro Open Access Project Officer LIBER Ligue des bibliothques europennes de recherche Open-Access-Tage Zrich, Sep 8 nd , 2015 The EC/OpenAIRE FP7 Post-Grant Open Access Pilot What is this FP7 Post-Grant Pilot? The EC

347 views • 14 slides
MOTION PREDICTION AS A FUNCTION OF TARGET SPEED AND DURATION OF PRESENTATION l EARL L. WIENER

MOTION PREDICTION AS A FUNCTION OF TARGET SPEED AND DURATION OF PRESENTATION l EARL L. WIENER

Journal of p p d y t y 1962, Vol. 46, No. 6, 420-424 MOTION PREDICTION AS A FUNCTION OF TARGET SPEED AND DURATION OF PRESENTATION l EARL L. WIENER University of Miami This study investigated ihe ability of Ss to predict the future position

175 views • 5 slides
Bayesian matrix factorization for drug-target activity prediction Yves Moreau University of

Bayesian matrix factorization for drug-target activity prediction Yves Moreau University of

Bayesian matrix factorization for drug-target activity prediction Yves Moreau University of Leuven ESAT-STADIUS SymBioSys Center for Computational Biology Number of new drugs per billion US$ 100 1950 10 1 2010 0.1 Scannell et al . 2012

1.03k views • 69 slides
branch prediction 1 last time what happens with TLB in access patterns overlapping TLB and

branch prediction 1 last time what happens with TLB in access patterns overlapping TLB and

branch prediction 1 last time what happens with TLB in access patterns overlapping TLB and cache index lookup overview of caches and page table lookups and TLB generally 3 an OOO pipeline combined with register-ready info to issue

1.36k views • 100 slides
AP Chemistry Compounds 2015-09-14 www.njctl.org Slide 3 / 163 Table of Contents: Compounds Pt.

AP Chemistry Compounds 2015-09-14 www.njctl.org Slide 3 / 163 Table of Contents: Compounds Pt.

Slide 1 / 163 Slide 2 / 163 AP Chemistry Compounds 2015-09-14 www.njctl.org Slide 3 / 163 Table of Contents: Compounds Pt. A Click on the topic to go to that section Chemical Formulas Metals & Alloys Ionic Compounds Covalent

697 views • 55 slides
Method For The Estimation Of Thermal Conductivity For Non- Electrolyte Organic Compounds Onellan

Method For The Estimation Of Thermal Conductivity For Non- Electrolyte Organic Compounds Onellan

University of KwaZulu Natal Chemical Engineering A New Group Contribution Method For The Estimation Of Thermal Conductivity For Non- Electrolyte Organic Compounds Onellan Govender 205502080 Experimentation Verses Prediction 2 Thermal

396 views • 23 slides
Investigation of Parallel Processing Using How to Enable/Access Open MPI in Open MPI ADMB.

Investigation of Parallel Processing Using How to Enable/Access Open MPI in Open MPI ADMB.

Why Open MPI? Investigation of Parallel Processing Using How to Enable/Access Open MPI in Open MPI ADMB. How is Open MPI Used in ADMB Now? Derek Seiple How it Works Development and Future ADMB Developers Workshop Directions March

820 views • 39 slides
Prediction of WVTR with General Regression Models Kimmo Lahtinen Session 9.1 1. Introduction

Prediction of WVTR with General Regression Models Kimmo Lahtinen Session 9.1 1. Introduction

TAMPERE UNIVERSITY OF TECHNOLOGY I n s t i t u t e o f P a p e r C o n v e r t i n g Prediction of WVTR with General Regression Models Kimmo Lahtinen Session 9.1 1. Introduction Target TARGET: To establish a practical, fast and

236 views • 23 slides
Update on open access Presentation by the Committee on the Library Jan 15th, 2019 Agenda 1. An

Update on open access Presentation by the Committee on the Library Jan 15th, 2019 Agenda 1. An

Update on open access Presentation by the Committee on the Library Jan 15th, 2019 Agenda 1. An update on negotiations with Elsevier 2. Current work in open access 3. OA2020 Expression of Interest (EoI) Why open access matters: Elsevier The

531 views • 6 slides
Open Access publishing TM6-3, University of Twente, 15 October 2019 Marit Eldholm PLATO Project

Open Access publishing TM6-3, University of Twente, 15 October 2019 Marit Eldholm PLATO Project

Open Access publishing TM6-3, University of Twente, 15 October 2019 Marit Eldholm PLATO Project Manager, ARENA Centre for European Studies, University of Oslo What is Open Access? Open Access is the free, immediate, online availability of

770 views • 17 slides
Plagiarism Detection in Open Access Publications Jens Brandt, Martin Gutbrod, Oliver Wellnitz,

Plagiarism Detection in Open Access Publications Jens Brandt, Martin Gutbrod, Oliver Wellnitz,

Plagiarism Detection in Open Access Publications Jens Brandt, Martin Gutbrod, Oliver Wellnitz, Lars Wolf 4th International Plagiarism Conference, 21-23 June 2010 Introduction Open Access Open Access Plagiarism Search Conclusion Outline

827 views • 24 slides
A Bottom-up Approach to OER Development: A Case Study Definitions OA (Open Access) OER (Open

A Bottom-up Approach to OER Development: A Case Study Definitions OA (Open Access) OER (Open

A Bottom-up Approach to OER Development: A Case Study Definitions OA (Open Access) OER (Open Educational Resources) 5 R Activities Affordable Course Materials OTN (Open Textbook Network) UALC Survey BYU 676 student participants 573

485 views • 47 slides
Open Access Research Data Sharing Dr Arthur Smith, Open Access Research Advisor Dr Marta

Open Access Research Data Sharing Dr Arthur Smith, Open Access Research Advisor Dr Marta

Open Access Research Data Sharing Dr Arthur Smith, Open Access Research Advisor Dr Marta Teperek, Research Data Facility Manager Office of Scholarly Communication Cambridge University Library / Research Operations Office Dr Andrew Thwaites,

620 views • 50 slides
Interactive Engagement Experiences: Next Level Open Access for Collections Access to Digital

Interactive Engagement Experiences: Next Level Open Access for Collections Access to Digital

Interactive Engagement Experiences: Next Level Open Access for Collections Access to Digital Collections Current State of Affairs: Traditional Access through Digital Archive http://digi.countrymusichalloffame.org/ Digitization for Access

783 views • 14 slides
A Presentation on Ishrat Ali Chief Mgr(Comml), CC Open Access in Inter-State Transmission System

A Presentation on Ishrat Ali Chief Mgr(Comml), CC Open Access in Inter-State Transmission System

A Presentation on Ishrat Ali Chief Mgr(Comml), CC Open Access in Inter-State Transmission System Open Access Grant Period As per Grant Responsibility New Amendment (Mar17) Long Term Access (LTA) Above 7 years CTU Medium Term Open 3

755 views • 53 slides

More recommend